A report on the European In Vitro Diagnostic Market has been recently published by Stratview Research. This Market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the European In Vitro Diagnostic Market. The historic years considered for the study are 2015-2020 the base year is 2021, and the forecast period is 2022-2025.
The study includes an in-depth analysis of type, application, and regional segments. It also includes a Market channel, distribution, and customer analysis, industry cost analysis, Market analysis by application, production, revenue, and price trend analysis by type, production and consumption analysis by region, and various other Market studies.
This report, from Stratview Research, studies the European in vitro diagnostics market over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
The Market is segmented by Products & Services (Reagents & Kits, Equipment, New Technology/Connect Laboratories (AI in lab), Data Management Services, Laboratory Support Services); By Technology (Immunohistochemistry, Clinical Chemistry, Molecular Diagnostics, Urinalysis, Hematology, Microbiology, POCT, Coagulation and Others); By Therapeutic Application (Infectious Diseases, Life Style Diseases (Diabetes, Obesity, etc), Oncology, Cardiology, Nephrology, Autoimmune Disorder and Drug Testing); By End User (Hospital – Laboratories / ICU/ Care Units, Hospitals – Patient Bedside (POCT), Advanced Clinical Laboratories (Referred by physicians), Self-Tests / Walk ins, Research and Academic Laboratories, Home users/ Aged Care/ Long Term Care/Hospice/ Community Care) and By Region (European Region, Germany, France, The United Kingdom.
This report also focuses on the short- and long-term implications of the novel Coronavirus pandemic on European In Vitro Diagnostic Market at the global, and regional dimensions. To evaluate the percentage of loss or profit to the industry, the report also compares pre-COVID and post-COVID scenarios.
The report delivers a detailed view of the industry based on European In Vitro Diagnostic Market size, Market growth, and opportunities. The report also analyses Market key aspects such as-
– Market structure: Overview, industry life cycle analysis, supply chain analysis
– Covid-19 Impact analysis.
– Market environment analysis: Growth drivers and constraints, and SWOT analysis.
– Market trend and forecast analysis.
– Market segment trend and forecast.
– Competitive landscape and dynamics: Market share, product launches, etc.
– Attractive Market segments and associated growth opportunities.
– Emerging trends.
– Strategic growth opportunities for the existing and new players.
The research provides in-depth analysis of the important elements that drive Market growth, including growth potential, opportunities, current Market trends, industry-specific obstacles, and dangers.
European In Vitro Diagnostics Market (Major Focus on Germany, France and The United Kingdom)
It should not come as a surprise that while the markets in Britain may face some fluctuations due to Brexit, major players in Britain are hopeful that with the new dynamics, newer opportunities will knock the doors of UK’s IVD market. Germany shall remain the market leader followed by France at No. 2 position, followed by Italy. Among the smaller nations, Poland, Czech Republic, Romania, Ireland and United Kingdom will show more growth than the remaining European nations. The report explores the opportunities and gaps in the top two IVD market of Europe as well as the most watched IVD market in 2018-2019, i.e., the UK.
On one hand the report deals with the Typology of out-of-pocket payments per country which varies in European member states which leads to varied payments by patients in different countries (impacts the cost of IVD tests) and on the other hand, it also looks at the attractive segments where IVD companies may come across decision makers and focus their marketing strategies accordingly. Infectious diseases, oncology, life style diseases shall remain the top three attractive segments in Europe.
Europe accounts for 23.4% of global cancer cases and 20.3% of cancer deaths, although it has only 9 per cent of the global population. Europe is characterized by striking geographical differences in cancer occurrence. There were an estimated 3.5 million new cancer cases and 1.9 million cancer deaths in Europe in 2012. Cancers of the female breast, colo-rectum, prostate and lung constitute over half of the overall incidences, while lung and colorectal cancer rank as the most common causes of cancer death. It widely varies from country to country.
In men, prostate cancer is the most frequent form of cancer incidence in most Northern, Western and Southern European countries, while lung cancer is the most frequently diagnosed cancer in Central and Eastern Europe. Lung cancer is the leading cause of cancer death among men in almost all European countries, while breast cancer dominates as the most frequent in women. Lung cancer is also a leading cause of cancer death in certain European countries among women, overtaking breast cancer.
While breast cancer incidence rates continued to increase in most European countries, mortality rates decreased, as a result of earlier diagnosis and improved therapies. IVD market is attractive and prominent among the oncologists. Besides, therapy area, the report highlights the attractiveness in products and services, end user markets.
Report Customization –
This report can be customized to meet the client’s obligations. Please get along with our sales team (email@example.com), who will ensure that you get a report that fits your needs. You can also touch a chord with our executives on +1-313-307-4176 to share your research constraints.
About Us –
Stratviewresearch.com is a leading global Market Research firm providing expert research solutions, trusted by clients worldwide. Stratview Research possesses a global presence to enable current Market information using the most up-to-date methodology, best-in-class research techniques, and cost-effective approaches. We survey clients in several countries to provide you with the most comprehensive illustration of global trends and behaviours.